Interviews

McMaster Perspective more

Cardiology more

Endocrinology more

  • The future of type 2 diabetes treatment
    The future of type 2 diabetes treatment
    With the current progress of medicine, can we expect that the use of insulin in people with type 2 diabetes will soon pass into history and the only injection therapy will involve effective drugs from the glucagon-like peptide-1 (GLP-1) receptor agonists, promoting significant weight loss?
  • Concentrated long-acting insulin analogues in type 2 diabetes
    Concentrated long-acting insulin analogues in type 2 diabetes
    What is the place of long-acting insulin analogues with higher than standard concentrations (200 IU/mL and 300 IU/mL) in the treatment of type 2 diabetes? In which patients should we expect the benefits to justify recommending the drug despite the higher cost to the patient?

Gastroenterology more

  • Cannabinoids in IBD
    Cannabinoids in IBD
    What is the role of cannabinoids in inflammatory bowel disease (IBD) management?
  • Diet and IBD
    Diet and IBD
    Is there any diet that reduces or sustains the remission of inflammatory bowel disease (IBD) in adult patients?

Hematology more

ICU & Emergencies more

Infectious Diseases more

  • Management of neglected tropical diseases now and in the future
    Management of neglected tropical diseases now and in the future
    What are the most important advances in the diagnosis, treatment, and prevention of tropical diseases in the past years? Can we expect any breakthrough in the treatment of neglected tropical diseases?
  • Epidemiologic changes in the post-COVID-19 era
    Epidemiologic changes in the post-COVID-19 era
    During the COVID-19 pandemic, many countries experienced difficulties in implementing vaccination programs and other infectious disease control measures. This affected the epidemiology of some diseases, with increase in the global number of malaria cases being an example. How significant are these epidemiologic changes for clinical practice?

Nephrology more

Neurology more

  • Management of patients with epilepsy
    Management of patients with epilepsy
    Could you please summarize the key advice for neurologists treating patients with drug-resistant epilepsy?
  • Cannabinoids in patients with epilepsy
    Cannabinoids in patients with epilepsy
    What is the current place of cannabidiol and other cannabinoids in the treatment of epilepsy? How often are OTC cannabinoid preparations used by patients with epilepsy in North America? How does it affect the clinical management of epilepsy?

Oncology more

Respirology more

Rheumatology more

Toxicology more

VTE more

Other more

We would love to hear from you

Comments, mistakes, suggestions?

We use cookies to ensure you get the best browsing experience on our website. Refer to our Cookies Information and Privacy Policy for more details.